Filing Details
- Accession Number:
- 0001209191-10-023461
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-23 13:00:00
- Reporting Period:
- 2010-04-21
- Filing Date:
- 2010-04-23
- Accepted Time:
- 2010-04-23 14:19:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1024003 | Jr C Joseph Cook | C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-04-21 | 73,427 | $1.66 | 777,411 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2010-04-21 | 61,190 | $1.66 | 476,016 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants | Disposition | 2009-10-16 | 73,427 | $0.13 | 73,427 | $1.66 |
| Common Stock | Warrants | Disposition | 2009-10-16 | 61,190 | $0.13 | 61,190 | $1.66 |
| Common Stock | Warrants | Acquisiton | 2010-04-21 | 73,427 | $0.13 | 73,427 | $2.96 |
| Common Stock | Warrants | Acquisiton | 2010-04-21 | 61,190 | $0.13 | 61,190 | $2.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-10-16 | 2012-10-16 | No | 4 | X | Direct |
| 0 | 2009-10-16 | 2012-10-16 | No | 4 | X | Direct |
| 73,427 | 2010-04-21 | 2013-04-21 | No | 4 | P | Direct |
| 61,190 | 2010-04-21 | 2013-04-21 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 304,600 | Direct | |
| Common Stock | 1,130,000 | Indirect | By Farview Mgmt Co. |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | $7.00 | 2012-04-17 | 50,000 | 50,000 | Direct | |
| Common Stock | Stock Option (right to buy) | $7.00 | 2013-11-23 | 25,000 | 25,000 | Direct | |
| Common Stock | Stock option (right to buy) | $2.70 | 2017-12-19 | 15,000 | 15,000 | Direct | |
| Common Stock | Warrants | $2.77 | 2008-03-25 | 2015-03-24 | 31,570 | 119,831 | Direct |
| Common Stock | Stock Option (right to buy) | $2.23 | 2018-06-10 | 15,000 | 15,000 | Direct | |
| Common Stock | Warrants | $2.77 | 2008-03-25 | 2015-03-24 | 14,402 | 14,402 | Indirect |
| Common Stock | Warrants | $2.77 | 2008-03-25 | 2015-03-24 | 25,649 | 25,649 | Direct |
| Common Stock | Stock option (right to buy) | $0.96 | 2019-06-11 | 30,000 | 30,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2012-04-17 | 50,000 | 50,000 | Direct |
| 2013-11-23 | 25,000 | 25,000 | Direct |
| 2017-12-19 | 15,000 | 15,000 | Direct |
| 2015-03-24 | 31,570 | 119,831 | Direct |
| 2018-06-10 | 15,000 | 15,000 | Direct |
| 2015-03-24 | 14,402 | 14,402 | Indirect |
| 2015-03-24 | 25,649 | 25,649 | Direct |
| 2019-06-11 | 30,000 | 30,000 | Direct |
Footnotes
- These securities are held by Farview Management Co., LLP, of which the reporting person is a general partner.
- Issuance of common stock upon exercise of warrants in accordance with the Securities Purchase Agreement dated as of October 12, 2009.
- Does not include 350,000 shares of which Mr. Cook disclaims any beneficial ownership interest.
- Immediately exercisable subject to a right of repurchase by Corcept Therapeutics Incorporated that shall lapse at the rate of 20% of the total option shares on 4/17/2003 and an additional 1.67% of the total option shares on each monthly anniverary of 4/17/2003 thereafter.
- Immediately exercisable subject to a right of repurchase by Corcept Therapeutics Incorporated that shall lapse at the rate of 20% of the total option shares on 11/23/2004 and an additional 1.67% of the total option shares on each monthly anniverary of 11/23/2004 thereafter.
- Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 11, 2007 so that the entirety of the option grant will vest within one year.
- Does not include 13,995 warrants of which Mr. Cook disclaims any beneficial ownership interest.
- Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 10, 2008 so that the entirety of the option grant will vest within one year.
- Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 11, 2009 so that the entirety of the option grant will vest on or before the date of Corcept's next Annual Meeting of Stockholders.
- Acquired from the issuer pursuant to a Warrant Purchase Agreement dated April 21, 2010 whereby purchase of the new warrants was conditioned upon the exercise of warrants that had been issued in October 2009 (see also Footnote #2 above).
Billionaire Hedge Funds
